Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 58.87 USD 1.1% Market Closed
Market Cap: 119.4B USD
Have any thoughts about
Bristol-Myers Squibb Co?
Write Note

Relative Value

The Relative Value of one BMY stock under the Base Case scenario is 75.18 USD. Compared to the current market price of 58.87 USD, Bristol-Myers Squibb Co is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BMY Relative Value
Base Case
75.18 USD
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
54
Median 3Y
2.8
Median 5Y
3.1
Industry
2.5
Forward
2.5
vs History
vs Industry
36
Median 3Y
16.3
Median 5Y
12.9
Industry
21.9
Forward
64.4
vs History
79
vs Industry
43
Median 3Y
8.8
Median 5Y
9.5
Industry
16.5
vs History
76
vs Industry
35
Median 3Y
11.3
Median 5Y
10.3
Industry
23.6
vs History
0
vs Industry
14
Median 3Y
4.5
Median 5Y
4
Industry
2.1
vs History
65
vs Industry
38
Median 3Y
3.4
Median 5Y
3.7
Industry
2.6
Forward
3.3
vs History
65
vs Industry
51
Median 3Y
4.4
Median 5Y
4.7
Industry
5.2
vs History
65
vs Industry
42
Median 3Y
7.4
Median 5Y
7.9
Industry
13.3
Forward
29.2
vs History
65
vs Industry
34
Median 3Y
14.4
Median 5Y
14.8
Industry
16.6
Forward
34.6
vs History
65
vs Industry
37
Median 3Y
10.8
Median 5Y
11.2
Industry
15.6
vs History
65
vs Industry
29
Median 3Y
11.6
Median 5Y
12
Industry
19.1
vs History
30
vs Industry
45
Median 3Y
1.8
Median 5Y
1.7
Industry
1.9

Multiples Across Competitors

BMY Competitors Multiples
Bristol-Myers Squibb Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bristol-Myers Squibb Co
NYSE:BMY
119.4B USD 2.5 -16.4 7.5 14.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Bristol-Myers Squibb Co
NYSE:BMY
Average P/E: 32.4
Negative Multiple: -16.4
63%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top